Effects of Butyrate Enemas on Colonic Health
1 other identifier
interventional
16
1 country
1
Brief Summary
Short chain fatty acids (mainly acetate, propionate and butyrate) are produced in the large intestine by bacterial fermentation of unabsorbed carbohydrates, such as dietary fibers. Mainly butyrate is an important energy source of the mucosa and has a pivotal role in the regulation of mucosal proliferation, immune function and mucosal protection. High fiber diets increase the concentrations of colonic butyrate, what has often been proposed as one of its protective mechanisms. Furthermore, butyrate enemas have been proved effective in the treatment of ulcerative colitis. In the present study the direct effects of butyrate on the distal colon will be studied in 30 healthy volunteers using rectal enemas. The study has been divided into two parts, each part studying different parameters, which interfere when measured synchronously and, therefore, need to be studied separately. A. The effects of butyrate enemas on colonic permeability (n=15) B. The effects of butyrate enemas on parameters of colonic defense, integrity and inflammation (n=15) The effects of butyrate will be studied in a healthy and in a stressed colon. This way the protective effects of butyrate on intestinal stress can be studied. Prior to the main study, two small pilot studies will be carried out. In the first pilot study the retrograde spread of a rectal enema will investigated (n=2). In the second pilot study the dose and the type of a suitable stressor that will induce reversible damage to intestinal mucosa will be determined (n=12).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable healthy
Started Dec 2005
Longer than P75 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2008
CompletedFirst Submitted
Initial submission to the registry
June 5, 2008
CompletedFirst Posted
Study publicly available on registry
June 9, 2008
CompletedFebruary 24, 2017
February 1, 2017
2.4 years
June 5, 2008
February 22, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
inflammatory parameters
Study Arms (2)
1
EXPERIMENTALsodium butyrate
2
PLACEBO COMPARATORNaCl
Interventions
Eligibility Criteria
You may qualify if:
- Age between 18 and 60 years old
- Good medical health according to a standard medical questionnaire
- Regular defecation pattern (at least once daily)
You may not qualify if:
- Use of medication other than oral anticonceptives
- Calcium supplementation (during the study)
- Caloric restriction diet (during the study)
- Excessive drinking (\>2 alcoholic consumptions a day)
- Drug abuse in the past six months and during the study
- Infectious disease (1 month prior to the study)
- Pregnant or lactating women
- Problems with urinary tract
- History of gastrointestinal complaints or disease(s)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Maastricht
Maastricht, Limburg, 6202MD, Netherlands
Related Publications (1)
Hamer HM, Jonkers DM, Bast A, Vanhoutvin SA, Fischer MA, Kodde A, Troost FJ, Venema K, Brummer RJ. Butyrate modulates oxidative stress in the colonic mucosa of healthy humans. Clin Nutr. 2009 Feb;28(1):88-93. doi: 10.1016/j.clnu.2008.11.002. Epub 2008 Dec 23.
PMID: 19108937DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fred Troost, PhD
Maastricht University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 5, 2008
First Posted
June 9, 2008
Study Start
December 1, 2005
Primary Completion
May 1, 2008
Study Completion
May 1, 2008
Last Updated
February 24, 2017
Record last verified: 2017-02